In an ADJUST-T1D follow-up, former semaglutide users lost a median 3.6 points of time in range within 3 months, even while on automated insulin delivery.
Recap by typeshit. Full story at Healio.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
Moss says he once believed GLP-1s caused far more muscle loss than ordinary calorie cutting. He now says he got that wrong.
Topol points to neoantigens, the proteins or peptides on cancer cell surfaces, as the base of personalized cancer therapies.
Researchers found 39% of GLP-1 users reported nail detachment, compared with 9% of non-users. The authors stress the data is self-reported and doesn't prove the drugs cause it.
An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
Loading…